Last Updated: September 2026
At the heart of clinical trial documentation lies the Trial Master File (TMF), a comprehensive repository of essential documents and data pertaining to the trial. Let's discuss this essential component of clinical trials.
What is a Trial Master File? A TMF is the comprehensive collection of documents and data that provides a complete record of how a clinical trial was conducted, organized per the TMF Reference Model's 11 zones. It exists to demonstrate GCP compliance and support regulatory audits and inspections — and today it's most often managed as an electronic Trial Master File (eTMF), a digital system offering version control, audit trails, and remote accessibility that a paper TMF can't.
Table of Contents
- What is the electronic Trial Master File (eTMF)?
- What Constitutes a Trial Master File?
- Documents Required in a Trial Master File
- Investigator Site File vs Trial Master File
- Managing Trial Master File Data
- Benefits of Using eTMF Software
- How Kivo Supports Trial Master File Management
- Frequently Asked Questions
What is an electronic trial master file?
An electronic trial master file is a digitized, centralized system for storing and managing all trial-related documents and data — offering enhanced accessibility, version control, and efficiency over a paper TMF.
An electronic trial master file is a digitized version of the traditional trial master file. It serves as a centralized, secure platform for storing and managing all trial-related documents and data electronically. Unlike its paper counterpart, an eTMF offers enhanced accessibility, version control, and efficiency in document management processes. eTMF is considered essential to meet Good Clinical Practice (GCP), which is required by multiple regulatory agencies including the EMA and MHRA.
Using electronic methods can accelerate clinical study timelines by streamlining data / correspondence collection, project management, and audit and inspection readiness, as well as significantly reducing manual workflows and tracking.
| Criteria | Paper TMF | Electronic TMF (eTMF) |
|---|---|---|
| Accessibility | Single physical location; remote review requires shipping or scanning documents on request. | Browser-based access for sponsors, CROs, sites, and inspectors from anywhere. |
| Version control | Manual tracking; easy to lose the authoritative version across multiple physical copies. | Automatic versioning with a full change history tied to each document. |
| Audit trail | Reconstructed manually from logs, sign-in sheets, and correspondence. | Automatic, uneditable, timestamped record of every action. |
| Inspection readiness | Completeness checks are manual and point-in-time. | Real-time completeness tracking and instant inspector access provisioning. |
| Long-term retention | Physical storage cost and degradation risk over a multi-year/decade retention period. | Digital storage with data-integrity checks; no physical degradation risk. |
What constitutes a trial master file?
A TMF must record every aspect of a trial's lifecycle, the process followed, and the resulting data demonstrating efficacy and compliance.
Every clinical trial must have a TMF. The TMF provides a record of all aspects of the clinical trial lifecycle, the process that was followed, and the resulting data showing efficacy. It provides evidence of compliance for regulatory agencies, investigators and auditors. Its primary purpose is to facilitate regulatory compliance, audit readiness, and the ability to reconstruct the trial from inception to completion. This includes protocols, informed consent forms, regulatory approvals, monitoring reports, and more.
Documents required in a trial master file
TMF document requirements come from ICH GCP, FDA 21 CFR Part 312, and FDA 21 CFR Part 11 — and the applicable version of ICH GCP is currently in transition.
The requirements for the trial master file are set by several key regulations, including ICH Good Clinical Practice, the FDA 21 CFR Part 312, and FDA 21 CFR Part 11 (or Part 11).
- ICH Good Clinical Practice is the international standard for human clinical trials, and it is currently transitioning from E6(R2) to ICH E6(R3). E6(R3)'s Principles and Annex 1 were adopted in January 2025 and have been in effect in the EU since July 2025; the FDA issued final E6(R3) guidance in September 2025 but has not yet set a formal US compliance date; Health Canada's implementation takes effect April 2026; and Annex 2 (covering decentralized and pragmatic trial elements) was adopted in June 2026, taking effect in the EU in January 2027. Because regional adoption is uneven, teams should confirm which version their regulatory authority currently expects rather than assume a flat replacement. See our guide to GCP-compliant eTMF for global clinical trials for what this means in practice.
- FDA 21 CFR Part 312 outlines the roles, responsibilities, and documentation required for investigational new drugs (INDs), a primary type of drug application.
- FDA 21 CFR Part 11 sets the standards for electronic records and signatures. If you are using any electronic system to store documents, be that a purpose-built eTMF system or a basic file sharing system like SharePoint or Box, it must meet Part 11 requirements.
Per these regulations, the eTMF should contain study-level, country-level, and site-level documents. These documents should be collected at multiple points during the study—from start-up through study close.
The structure of the TMF is defined by the TMF Reference Model per CDISC. The sections, or Zones, are outlined as follows:
- Trial Management
- Central Trial Documents
- Regulatory
- IRB, IEC and other Approvals
- Site Management
- IP and Trial Supplies
- Safety Reporting
- Central and Local Testing
- Third Parties
- Data Management
- Statistics
A sample of the key documents that need to be included per ICH GCP include:
- Investigator Brochure (IB)
- Signed Protocols, Amendments and CRF
- Informed Consent Forms (ICF & HIPAA Authorizations)
- Patient Recruitment Documentation
- Insurance Statement
- Signed Agreements between investigators, institutions, sponsors, CROs, etc
- Institutional Review Board (IRB) Approvals and Correspondence
- Investigator CVs
- Investigational Product (IP)
- Financial Disclosure Form (FDF)
- Training Logs
- Monitoring Logs
- Signature Logs
- Signature Sheets (SS)
- Statement of Investigator (FDA Form 1572)
To view the full list of essential documents, refer directly to the ICH E6 documentation.
Investigator Site File vs Trial Master File
The Investigator Site File shares many documents with the Sponsor's TMF, but each party owns different pieces of it.
The Investigator Site File, now referred to as the Site File by regulators, shares many documents with the Sponsor's TMF. The Site File is maintained by the investigators and contains site-specific documents, regulatory documents, and protocol information, as does the Sponsor TMF. Investigators are responsible for certain documents, while Sponsors are responsible for others. The TMF Reference Model delineates which elements of the TMF should be managed by the Sponsor vs the Investigator, as well as which documents are shared between parties. Given the overlap, maintaining clear communication, a delineation of responsibilities, and a shared structure for documents can significantly reduce confusion and version control issues. Using an electronic trial master file system that both parties can access can improve data integrity, collaboration, and streamline project timelines.
Managing Trial Master File Data
Effective TMF data management requires access controls, data security, and a plan for retention that varies by jurisdiction — retention obligations don't end when the study does.
Effective data management in TMFs involves meticulous attention to detail and adherence to regulatory guidelines. This includes the incorporation of revised documentation, stringent access controls, robust data security measures, and redundant data storage to safeguard against loss or corruption.
Retention requirements don't end at study closeout, and they vary meaningfully by region and regulatory framework — some jurisdictions have extended their required retention periods well beyond what sponsors historically planned for. See our dedicated guide on TMF archiving after study closeout for current, region-specific retention rules and what a compliant long-term archive needs to support.
Proper data management of the TMF is the subject of numerous whitepapers, webinars, conferences, and more! To learn more about best practices for TMF management, reach out to our team or visit our resources page.
Benefits of Using eTMF Software
eTMF software streamlines document workflows, real-time collaboration, and regulatory compliance — and lets teams track TMF completeness in real time rather than discovering gaps at inspection.
The adoption of eTMF software offers a multitude of advantages for sponsors, CROs, and other stakeholders involved in clinical trials. From streamlining document workflows to facilitating real-time collaboration and ensuring regulatory compliance, eTMF software significantly enhances operational efficiency and data integrity throughout the trial lifecycle. Moreover, utilizing eTMF from the outset minimizes the need for labor-intensive processes such as digitizing and validating paper documents, thus optimizing resource allocation and accelerating time-to-market for investigational therapies. Tracking real-time TMF completeness metrics is one of the clearest ways teams catch missing or misfiled documents before they become an inspection finding.
Many sponsors choose to use their CRO's eTMF system, or leverage a patchwork of file sharing solutions rather than implement their own eTMF. However, implementing a digital eTMF in-house can streamline operations and improve compliance.
Wondering if an eTMF system would be right for you? Check out this article on When and Why to Implement an eTMF. If you're starting evaluations, read through our guide on how to select your eTMF system.
How Kivo supports trial master file management
Kivo's eTMF runs on the same document core as its DMS, RIM, and QMS modules, so trial documentation, regulatory submissions, and quality records stay connected rather than living in separate systems.
Kivo's eTMF includes native, Part 11-compliant electronic signature at no additional charge, and supports TMF migration from virtually any prior system via secure FTP — recompiling a single, unified audit trail even for documents that passed through multiple previous platforms (Kivo's Elevar Therapeutics case study documents 19 TMF studies, 73,794 documents, migrated in 72 days). For long-term storage after study closeout, Kivo doesn't charge per-GB or per-study, and applies quarterly data-integrity checksums along with read-only document states and maintained audit trails. Inspector-specific access can be granted in minutes, showing only final, non-draft versions.
Frequently asked questions
What is a Trial Master File?
A Trial Master File (TMF) is the comprehensive repository of essential documents and data that provides a complete record of a clinical trial's conduct, used to demonstrate regulatory compliance and support audits and inspections.
What's the difference between a TMF and an eTMF?
A TMF is the collection of required trial documents; an eTMF (electronic Trial Master File) is a digital system for creating, organizing, storing, and managing those documents, offering version control, audit trails, and remote accessibility that a paper TMF does not.
What documents are required in a Trial Master File?
Required documents are defined by ICH GCP, FDA 21 CFR Part 312, and FDA 21 CFR Part 11, and include protocols and amendments, informed consent forms, investigator brochures, IRB/IEC approvals and correspondence, monitoring reports, and more, organized per the TMF Reference Model's zones.
How long must a Trial Master File be retained after study closeout?
Retention periods vary by jurisdiction and regulatory framework, and some regions have extended requirements well beyond a trial's active period — see our guide to TMF archiving after study closeout for current, region-specific rules.
What should you look for in an eTMF storage or archiving solution?
Look for validated, audit-trail-preserving storage with role-based access controls, no per-GB or per-study cost penalties for long-term retention, and periodic data-integrity checks.
Conclusion
In conclusion, understanding the intricacies of trial master files is fundamental for ensuring the successful execution and oversight of clinical trials. Whether in its traditional or electronic form, the TMF serves as a cornerstone of regulatory compliance, data integrity, and ultimately, the advancement of medical science.
